Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.52 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3464415 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL3464413 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2391893 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2819570 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL16294105 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2393800 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL3464844 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2387925 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL2390985 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 | |
| SCHEMBL3464839 | 1.00 | BLM (0.52) | BLMGABRR1GABRR2LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2111391-B9 | NEW UNSATURATED FATTY AMINO-ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY | FABRE PIERRE DERMO COSMETIQUE (FR) | 2013-05-29 | — | — | EP | claimed |
| EP-2111391-B1 | NEW UNSATURATED FATTY AMINO-ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY | FABRE PIERRE DERMO COSMETIQUE (FR) | 2012-10-31 | — | — | EP | claimed |
| EP-2188380-B1 | Method for the coproduction of methyl 7-oxoheptanoate and undecylenic acid from ricinoleic acid | ARKEMA FRANCE (FR) | 2011-05-11 | — | — | EP | claimed |
| US-20040249114-A1 | Methods of synthesis of polysuccinimide or polyaspartate by end capping polymerization | SWIFT GRAHAM (US) | 2004-12-09 | — | — | US | claimed |
| US-20040249115-A1 | Methods of synthesis of poly(succinimide-aspartate) copolymer by end-capping polymerization | FOLIA, INC. | 2004-12-09 | — | — | US | claimed |
| US-20260101895-A1 | FUNGICIDAL AGENT AND COMPOSITION | INNOSPEC LTD (GB) | 2026-04-16 | — | — | US | disclosed |
| EP-4598349-A1 | FUNGICIDAL AGENT AND COMPOSITION | Innospec Limited (GB) | 2025-08-13 | — | — | EP | disclosed |
| CN-115784866-B | Method for preparing undecylenic acid by hydrolyzing methyl undecylenate | 中国五环工程有限公司 | 2025-05-23 | — | — | CN | disclosed |
| WO-2024074809-A1 | FUNGICIDAL AGENT AND COMPOSITION | INNOSPEC LIMITED (GB) | 2024-04-11 | — | — | WO | disclosed |
| CN-116693843-A | Preparation method of nylon 11 | 中国科学院微生物研究所 | 2023-09-05 | — | — | CN | disclosed |
| CN-115368556-B | Method and system for preparing nylon 11 from bio-based castor oil | 中国五环工程有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-116063171-A | Method for preparing undecylenic acid by medium-low temperature catalytic hydrolysis | 中国五环工程有限公司 | 2023-05-05 | — | — | CN | disclosed |
| EP-1292789-A1 | THERMOPLASTIC PIPELINE-LINER NOT REQUIRING VENTING OF THE ANNULUS BETWEEN THE LINER AND THE HOST PIPE | Atofina Chemicals, Inc. (US) | 2003-03-19 | — | — | EP | disclosed |
| US-20020157718-A1 | Thermoplastic pipeline-liner not requiring venting of the annulus between the liner and the host pipe | ATOFINA CHEMCIALS, INC. | 2002-10-31 | — | — | US | disclosed |
| US-20020022670-A1 | For production of mono- and multifilaments, fibers, films and nets | EMS-CHEMIE AG (CH) | 2002-02-21 | — | — | US | disclosed |
| WO-2002001103-A1 | THERMOPLASTIC PIPELINE-LINER NOT REQUIRING VENTING OF THE ANNULUS BETWEEN THE LINER AND THE HOST PIPE | ATOFINA CHEMICALS, INC. (US) | 2002-01-03 | — | — | WO | disclosed |
| US-4567238-A | THERMOPLASTIC ELASTOMERS | TOYODA GOSEI CO., LTD. (JP) | 1986-01-28 | — | — | US | disclosed |
| EP-0140372-A2 | Polyamide-rubber blended composition | Toyoda Gosei Co., Ltd. (JP) | 1985-05-08 | — | — | EP | disclosed |
| US-4145474-A | Method of manufacturing insulated electric wire of the enamelled-wire type by extrusion | MAILLEFER S.A. (CH) | 1979-03-20 | — | — | US | disclosed |
| US-3956213-A | Suspension agent for synthetic plastics powder | KUFNER TEXTILWERKE KG. (DT) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101895-A1 | FUNGICIDAL AGENT AND COMPOSITION | SLC7A1, AOC1, AOC2 | BLM 4715/4885GABRR1 2626/4885GABRR2 2930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.